| Drug Name |
Omega-3-fatty acids |
| Drug ID |
BADD_D01613 |
| Description |
Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that originally come from microalgae that is further consumed by phytoplankton, a source of diet for fish). Omega-3 fatty acids play a critical role in metabolism and cellular function and they are available as daily supplements. On September 8, 2004, the U.S. Food and Drug Administration gave "qualified health claim" status to EPA and DHA omega-3 fatty acids. Therapeutic products containing omega-3 fatty acid and its derivatives for treatment of hypertriglyceridemia include Lovaza, Omtryg, Epanova, and Vascepa. |
| Indications and Usage |
Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia. |
| Marketing Status |
Not Available |
| ATC Code |
Not Available |
| DrugBank ID |
DB11133
|
| KEGG ID |
Not Available
|
| MeSH ID |
D015525
|
| PubChem ID |
56842239
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| Synonyms |
Fatty Acids, Omega-3 | Omega-3 Fatty Acid | Acid, Omega-3 Fatty | Fatty Acid, Omega-3 | Omega 3 Fatty Acid | Omega-3 Fatty Acids | n-3 Oil | Oil, n-3 | n 3 Oil | n3 Oil | Oil, n3 | n-3 Fatty Acids | n 3 Fatty Acids | Omega 3 Fatty Acids | n-3 PUFA | PUFA, n-3 | n 3 PUFA | n3 Fatty Acid | Fatty Acid, n3 | n3 PUFA | PUFA, n3 | n3 Polyunsaturated Fatty Acid | n3 Oils | n-3 Oils | n 3 Oils | N-3 Fatty Acid | Acid, N-3 Fatty | Fatty Acid, N-3 | N 3 Fatty Acid | n-3 Polyunsaturated Fatty Acid | n 3 Polyunsaturated Fatty Acid |
